CSIMarket Company Name, Ticker, Competitors, else..


Viridian Therapeutics Inc   (NASDAQ: VRDN)
Other Ticker:  
 
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Viridian Therapeutics Inc

VRDN's Fundamental analysis



Viridian Therapeutics Inc 's sales fell by 0 % in IV. Quarter 2024 from the same quarter a year ago. Ranking at No. 1880

Medical Laboratories industry recorded growth of revenues by 6.35 %

Viridian Therapeutics Inc net loss increased from $-67 millions, to $-80 millions in IV. Quarter 2024,

• More on VRDN's Growth


Viridian Therapeutics Inc
realized a net loss in trailing twelve months.

Viridian Therapeutics Inc realized cash reduction of $ -0.04 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 3930.7.
Medical Laboratories industry's Price to Sales ratio is at 2.17.


• More on VRDN's Valuation
 
 Total Debt (Millions $) 21
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 4,314
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 6.94

Viridian Therapeutics Inc
realized net loss in trailing twelve months.

Viridian Therapeutics Inc realized cash outflow of $ -0.04per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 3930.7.
Medical Laboratories industry's Price to Sales ratio is at 2.17.

Viridian Therapeutics Inc Price to Book Ratio is at 1.77 lower than Industry Avg. of 147.07. and higher than S&P 500 Avg. of 0.01

• More on VRDN's Valuation

•  Market Capitalization (Millions $) 1,187
•  Shares Outstanding (Millions) 88
•  Employees 70
•  Revenues (TTM) (Millions $) 0
•  Net Income (TTM) (Millions $) -270
•  Cash Flow (TTM) (Millions $) -3
•  Capital Exp. (TTM) (Millions $) -1
•  Total Debt (Millions $) 21
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 4,314
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 6.94

•  Market Capitalization (Millions $) 1,187
•  Shares Outstanding (Millions) 88
•  Employees 70
•  Revenues (TTM) (Millions $) 0
•  Net Income (TTM) (Millions $) -270
•  Cash Flow (TTM) (Millions $) -3
•  Capital Exp. (TTM) (Millions $) -1





  Ratio
•   Capital Ratio (MRQ) 15.52
•  Total Debt to Equity (MRQ) 0.03
•  Tangible Leverage Ratio (MRQ) 0.1
•  Asset Turnover Ratio (TTM) 0
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com